COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
NanoViricides, Inc. reports positive results of NV-387 in protecting lungs from damage in influenza virus infection. NV-387 treatment showed reduced lung infiltration, cell death, mucus load, and increased survival -
COMMUNIQUÉ DE PRESSE
MindBio Therapeutics Reports Sustained Antidepressant Response from MB22001 in Depression Clinical Trials
MindBio Therapeutics reports significant and sustained reduction in depression symptoms with MB22001 microdosing trials. Phase 2B trials show promise for mental health treatment -
COMMUNIQUÉ DE PRESSE
MindBio Therapeutics Reports Sustained Antidepressant Response from MB22001 in Depression Clinical Trials
MindBio Therapeutics Corp. reports Phase 2A clinical trials results showing substantial and sustained reduction in depression symptoms with MB22001, a self-administered microdose of LSD -
-
-
-
COMMUNIQUÉ DE PRESSE
INSIDE INFORMATION / OTHER NEWS RELEASES
Verimatrix annonce la mise à jour de Verimatrix XTD Dashboard, offrant une nouvelle approche en matière de visibilité des risques et d'actions. Nouvelle classification des risques, tags d'identité et améliorations de l'expérience utilisateur -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Varengold Bank AG receives audit certificate for the 2022 annual financial statements with unqualified audit opinion
Varengold Bank AG receives unqualified audit opinion for 2022 annual financial statements after significant delays due to special audit, reports 18.9% higher EBT of EUR 25.4 million compared to 2021 -
